Stephen O. Brennan

3.2k total citations · 1 hit paper
105 papers, 2.5k citations indexed

About

Stephen O. Brennan is a scholar working on Pulmonary and Respiratory Medicine, Hematology and Physiology. According to data from OpenAlex, Stephen O. Brennan has authored 105 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Pulmonary and Respiratory Medicine, 29 papers in Hematology and 25 papers in Physiology. Recurrent topics in Stephen O. Brennan's work include Blood properties and coagulation (65 papers), Erythrocyte Function and Pathophysiology (24 papers) and Hemoglobinopathies and Related Disorders (14 papers). Stephen O. Brennan is often cited by papers focused on Blood properties and coagulation (65 papers), Erythrocyte Function and Pathophysiology (24 papers) and Hemoglobinopathies and Related Disorders (14 papers). Stephen O. Brennan collaborates with scholars based in New Zealand, United States and Germany. Stephen O. Brennan's co-authors include Robin W. Carrell, Maurice C. Owen, Peter M. George, Jessica H. Lewis, D. Ross Boswell, Jan‐Olof Jeppsson, Lloyd Vaughan, Carl‐Bertil Laurell, Peter M. George and Andrew Fellowes and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Stephen O. Brennan

104 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Structure and variation of human α1–antitrypsin

1982 521 citations Robin W. Carrell, Stephen O. Brennan et al. profile →

Peers

Countries citing papers authored by Stephen O. Brennan

Since Specialization

Citations

This map shows the geographic impact of Stephen O. Brennan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen O. Brennan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen O. Brennan more than expected).

Fields of papers citing papers by Stephen O. Brennan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen O. Brennan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen O. Brennan. The network helps show where Stephen O. Brennan may publish in the future.

Co-authorship network of co-authors of Stephen O. Brennan

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen O. Brennan. A scholar is included among the top collaborators of Stephen O. Brennan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen O. Brennan. Stephen O. Brennan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting a Novel Site in Exon 51 with Antisense Oligonucleotides Induces Enhanced Exon Skipping in a Mouse Model of Duchenne Muscular Dystrophy 2025 ·Nucleic Acid Therapeutics ·(unknown), (unknown), Joshua Henshaw, Kevin Larimore, Andrew C. Melton, Jukka Puoliväli, (unknown), (unknown), Stephen O. Brennan, (unknown), Monika Abedin Sigg, Brett E. Crawford, (unknown), Steven Froelich, Josh C. Woloszynek, Charles O’Neill	1
2	Unique albumin with two silent substitutions (540Thr→Ala and 546Ala→Ser): Insights into how albumin is recycled 2016 ·Clinica Chimica Acta ·Stephen O. Brennan, Howard Potter, Campbell R. Sheen, Peter M. George	3
3	Variation of fibrinogen oligosaccharide structure in the acute phase response: Possible haemorrhagic implications 2015 ·PubMed ·Stephen O. Brennan	9
4	Novel fibrinogen mutations (Aα17Gly→Cys and Aα381Ser→Phe) occurring with a 312Thr→Ala polymorphism 2015 ·Blood Coagulation & Fibrinolysis ·Stephen O. Brennan, Andrew D. Laurie, (unknown), Andrew Grigg	4
5	Acquired and congenital fast albumin bands; insights from electrospray TOF analysis of whole plasma into drug binding and albumin recycling 2015 ·Clinical Biochemistry ·Stephen O. Brennan, Richard Mackay	1
6	Hb Ashburton [β12(A9)Thr → Pro; HBB : c.37A > C], a Novel, Mildly Unstable Variant and the First Substitution Identified at Codon 12 2014 ·Hemoglobin ·Stephen O. Brennan, (unknown), Ulrich Lankes	2
7	A novel mutation in the FGB: c.1105C>T turns the codon for amino acid Bβ Q339 into a stop codon causing hypofibrinogenemia 2012 ·Blood Cells Molecules and Diseases ·Rita Marchi, Stephen O. Brennan, Michael Meyer, Héctor Rojas, (unknown), (unknown), Arlette Ruiz‐Sàez	4
8	Fibrinogen Melbourne 2012 ·Blood Coagulation & Fibrinolysis ·Chan Y. Cheah, Stephen O. Brennan, Hannah Kennedy, E. Januszewicz, Ellen Maxwell, Kate Burbury	9
9	Lungfish albumin is more similar to tetrapod than to teleost albumins: Purification and characterisation of albumin from the Australian lungfish, Neoceratodus forsteri 2007 ·Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology ·Victoria Metcalf, Peter M. George, Stephen O. Brennan	22
10	Mutant Fibrinogen Cleared from the Endoplasmic Reticulum via Endoplasmic Reticulum-Associated Protein Degradation and Autophagy 2006 ·American Journal Of Pathology ·Kristina B. Kruse, (unknown), Erin Kaltenbrun, (unknown), Peter M. George, Stephen O. Brennan, Ardythe A. McCracken	77
11	beta-Secretase Activity in Human Platelets 2004 ·Neurobiology of Aging ·(unknown), Stephen O. Brennan, (unknown), Peter Passmore, Janet Johnston	4
12	Fibrinogen Mannheim II: a novel γ307 His→Tyr substitution in the γD domain causes hypofibrinogenemia 2004 ·Journal of Thrombosis and Haemostasis ·(unknown), C.‐E. Dempfle, Stephen O. Brennan, (unknown), Peter M. George	13
13	Latent antithrombin and its detection, formation and turnover in the circulation 2004 ·Journal of Thrombosis and Haemostasis ·(unknown), Gary B. Evans, Stephen O. Brennan, Robin W. Carrell, Aiwu Zhou	42
14	Familial hypofibrinogenaemia associated with heterozygous substitution of a conserved arginine residue; Bβ255 Arg→His (Fibrinogen Merivale) 2003 ·Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics ·Ghassan J. Maghzal, Stephen O. Brennan, Andrew Fellowes, Ruth Spearing, Peter M. George	19
15	Novel Aα chain truncation (fibrinogen Perth) resulting in low expression and impaired fibrinogen polymerization 2003 ·Journal of Thrombosis and Haemostasis ·(unknown), (unknown), Stephen O. Brennan, Amy Barr, Peter M. George	16
16	Genetic and Immunological Characterization of Fibrinogen Inclusion Bodies in Patients with Hepatic Fibrinogen Storage and Liver Disease 2001 ·Annals of the New York Academy of Sciences ·Daniela Medicina, Giovanna Fabbretti, Stephen O. Brennan, Peter M. George, (unknown), Francesco Callea	23
17	HB Auckland [α87(F8)his→ASN]: A new Mutation of the Proximal Histidine Identified by Electrospray Mass Spectrometry 1997 ·Hemoglobin ·Stephen O. Brennan, (unknown)	18
18	Aberrant hepatic processing causes removal of activation peptide and primary polymerisation site from fibrinogen Canterbury (A alpha 20 Val --> Asp). 1995 ·Journal of Clinical Investigation ·Stephen O. Brennan, (unknown), Peter M. George	52
19	Structural characterization of a glycoprotein variant of human serum albumin: albumin Casebrook (494Asp → Asn) 1991 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Robert Peach, Stephen O. Brennan	40
20	Endopeptidase-24.11 in human plasma degrades atrial natriuretic factor (ANF) to ANF(99–105/106–126) 1989 ·Peptides ·Timothy G. Yandle, Stephen O. Brennan, Eric A. Espiner, (unknown), Mark Richards	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact